On Demand

Exploring MolDX and Payer Guidelines for Molecular Testing

  • Credit:1.0 ACCENT
  • Duration: 1 hour
  • Date:JAN.25.2023 12:00 p.m. - 01:00 p.m.
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

This webinar was recorded live on January 25, 2023.
It is available on demand through January 31, 2024.
Register above for access.


Labs performing molecular infectious disease testing within a MolDX jurisdiction must now register for a unique DEX code z-identifier to receive a fixed reimbursement for laboratory developed tests or “expanded” panels that test for more than five targets. During this webinar we will review the MolDX program, and under which conditions the labs need to apply for a new Z-code.

At the end of the webinar the attendees will have an understanding of the reimbursement landscape for molecular testing and how the new MolDX requirements should be applied in daily routine.


This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.


At the end of this activity, participants will be able to:

  • Define what MolDX and Z-codes are.
  • Identify the rules for payment in Local Coverage Determinations (LCDs)/Payer Policy.
  • Explain Laboratory Benefit Management (LBM) and its role in payer policy and reimbursement for laboratory testing
  • Define the role of Medical Necessity in the reimbursement landscape.


Jon HarolJon Harol
Lighthouse Lab Services
Charlotte, NC, USA

Ann LambrixAnn Lambrix
Vice President, RCM Solutions
Lighthouse Lab Services
Charlotte, NC, USA


The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported no relevant financial relationship:

  • Jon Harol
  • Ann Lambrix


All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.


This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 4165. This activity was planned in accordance with ACCENT® Standards and Policies.


Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].

Sponsored By

Thermo Fisher Logo